new med for type 2 diabetes, Avandia (rosiglitazone)

There's now a new med for type 2 diabetes, Avandia (rosiglitazone)...from SmithKline Beecham and Bristol-Myers Squibb.

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

All three lower blood glucose by improving insulin sensitivity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote